Focus on multiple myeloma

被引：133

作者：

Mitsiades, CS ^{[1
]}

Mitsiades, N

Munshi, NC

Anderson, KC

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Jerome Lipper Multiple Myeloma Ctr, Boston, MA 02115 USA

[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

来源：

CANCER CELL | 2004年 / 6卷 / 05期

关键词：

D O I：

10.1016/j.ccr.2004.10.020

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：439 / 444

页数：6

共 64 条

[51] RANK (receptor activator of nuclear factor-κB) and RANKL expression in multiple myeloma [J].

Roux, S ;

Meignin, V ;

Quillard, J ;

Meduri, G ;

Guiochon-Mantel, A ;

Fermand, JP ;

Milgrom, E ;

Mariette, X .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (01) :86-92

[52] Telomerase inhibition and cell growth arrest after telomestatin treatment in multiple myeloma [J].

Shammas, MA ;

Reis, RJS ;

Li, C ;

Koley, H ;

Hurley, LH ;

Anderson, KC ;

Munshi, NC .

CLINICAL CANCER RESEARCH, 2004, 10 (02) :770-776

[53] Prognostic impact of cytogenetic and interphase fluorescence in situ hybridization-defined chromosome 13 deletion in multiple myeloma:: early results of total therapy II [J].

Shaughnessy, J ;

Tian, E ;

Sawyer, J ;

McCoy, J ;

Tricot, G ;

Jacobson, J ;

Anaissie, E ;

Zangari, M ;

Fassas, A ;

Muwalla, F ;

Morris, C ;

Barlogie, B .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (01) :44-52

[54]

Shi YJ, 2002, CANCER RES, V62, P5027

[55] Diverse karyotypic abnormalities of the c-myc locus associated with c-myc dysregulation and tumor progression in multiple myeloma [J].

Shou, YP ;

Martelli, ML ;

Gabrea, A ;

Qi, Y ;

Brents, LA ;

Roschke, A ;

Dewald, G ;

Kirsch, IR ;

Bergsagel, PL ;

Kuehl, WM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (01) :228-233

[56] Antitumor activity of thalidomide in refractory multiple myeloma. [J].

Singhal, S ;

Mehta, J ;

Desikan, R ;

Ayers, D ;

Roberson, P ;

Eddlemon, P ;

Munshi, N ;

Anaissie, E ;

Wilson, C ;

Dhodapkar, M ;

Zeldis, J ;

Barlogie, B ;

Siegel, D ;

Crowley, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (21) :1565-1571

[57] RANK-Fc: A therapeutic antagonist for RANK-L in myeloma [J].

Sordillo, EM ;

Pearse, RN .

CANCER, 2003, 97 (03) :802-812

[58] The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma [J].

Tian, E ;

Zhan, FH ;

Walker, R ;

Rasmussen, E ;

Ma, YP ;

Barlogie, B ;

Shaughnessy, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (26) :2483-2494

[59] The development of a model for the homing of multiple myeloma cells to human bone marrow [J].

Urashima, M ;

Chen, BP ;

Chen, S ;

Pinkus, GS ;

Bronson, RT ;

Dedera, DA ;

Hoshi, Y ;

Teoh, G ;

Ogata, A ;

Treon, SP ;

Chauhan, D ;

Anderson, KC .

BLOOD, 1997, 90 (02) :754-765

[60]

Vanderkerken K, 2003, CANCER RES, V63, P287

← 1 2 3 4 5 6 7 →